{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T16:55:56Z","timestamp":1758992156710,"version":"3.37.3"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001921","name":"Public Health Research Programme","doi-asserted-by":"publisher","award":["cdrf2014-05-057"],"award-info":[{"award-number":["cdrf2014-05-057"]}],"id":[{"id":"10.13039\/501100001921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13643-016-0203-y","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T06:39:59Z","timestamp":1455345599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol"],"prefix":"10.1186","volume":"5","author":[{"given":"Mohammad O.","family":"Tallouzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie","family":"Calvert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip I.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas","family":"Bucknall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alastair K.","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,13]]},"reference":[{"issue":"4","key":"203_CR1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000078612","volume":"218","author":"O Durrani","year":"2004","unstructured":"Durrani O, Meads C, Murray P. Uveitis: a potentially blinding disease. Ophthalmologica. 2004;218(4):223\u201336.","journal-title":"Ophthalmologica"},{"issue":"1","key":"203_CR2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/bjo.2006.101386","volume":"91","author":"GJ Williams","year":"2007","unstructured":"Williams GJ, Brannan S, Forrester JV, Gavin MP, Paterson-Brown SP, Purdie A, et al. The prevalence of sight-threatening uveitis in Scotland. Br J Ophthalmol. 2007;91(1):33\u20136.","journal-title":"Br J Ophthalmol"},{"key":"203_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/509456","volume":"2015","author":"MR Abdulaal","year":"2015","unstructured":"Abdulaal MR, Abiad BH, Hamam RN. Uveitis in the aging eye: incidence, patterns, and differential diagnosis. J Ophthalmol. 2015;2015:1\u20138.","journal-title":"J Ophthalmol"},{"issue":"6","key":"203_CR4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.4103\/0301-4738.114090","volume":"61","author":"NA Rao","year":"2013","unstructured":"Rao NA. Uveitis in developing countries. Indian J Ophthalmol. 2013;61(6):253\u20134.","journal-title":"Indian J Ophthalmol"},{"key":"203_CR5","first-page":"36","volume":"136","author":"E Vadot","year":"1984","unstructured":"Vadot E, Barth E, Billet P. Epidemiology of uveitis\u2014preliminary results of a prospective study in Savoy. Uveitis update Amsterdam: Elsevier. 1984;136:36\u201340.","journal-title":"Uveitis update Amsterdam: Elsevier"},{"issue":"4","key":"203_CR6","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/bjo.80.4.332","volume":"80","author":"A Rothova","year":"1996","unstructured":"Rothova A, Suttorp-van Schulten M, Treffers WF, Kijlstra A. Causes and frequency of blindness in patients with intraocular inflammatory disease. Br J Ophthalmol. 1996;80(4):332\u20136.","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"203_CR7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0002-9394(14)74235-7","volume":"103","author":"E Bloch-Michel","year":"1987","unstructured":"Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234\u20135.","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"203_CR8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","volume":"140","author":"DA Jabs","year":"2005","unstructured":"Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140(3):509\u201316.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"203_CR9","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.ophtha.2006.03.027","volume":"113","author":"CW Lardenoye","year":"2006","unstructured":"Lardenoye CW, Van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446\u20139.","journal-title":"Ophthalmology"},{"issue":"2","key":"203_CR10","first-page":"60","volume":"7","author":"J Davis","year":"2010","unstructured":"Davis J. Current concepts in the management of uveitic macular edema. Advanced Studies in Ophthalmology. 2010;7(2):60\u20136.","journal-title":"Advanced Studies in Ophthalmology"},{"key":"203_CR11","first-page":"311","volume":"107","author":"PK Kaiser","year":"2009","unstructured":"Kaiser PK. Prospective evaluation of visual acuity assessment: a comparison of Snellen versus ETDRS charts in clinical practice (an AOS thesis). Trans Am Ophthalmol Soc. 2009;107:311\u201324.","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"203_CR12","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2013.09.023","volume":"12","author":"MH Levin","year":"2014","unstructured":"Levin MH, Pistilli M, Daniel E, Gangaputra SS, Nussenblatt RB, Rosenbaum JT, et al. Incidence of visual improvement in uveitis cases with visual impairment caused by macular edema. Ophthalmology. 2014;12(2):588\u201395. e1.","journal-title":"Ophthalmology"},{"issue":"3","key":"203_CR13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/09273948.2012.658467","volume":"20","author":"SR Taylor","year":"2012","unstructured":"Taylor SR, Lightman SL, Sugar EA, Jaffe GJ, Freeman WR, Altaweel MM, et al. The impact of macular edema on visual function in intermediate, posterior, and panuveitis. Ocul Immunol Inflamm. 2012;20(3):171\u201381.","journal-title":"Ocul Immunol Inflamm"},{"issue":"3","key":"203_CR14","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/archopht.122.3.330","volume":"122","author":"JC Brown","year":"2004","unstructured":"Brown JC, Solomon SD, Bressler SB, Schachat AP, DiBernardo C, Bressler NM. Detection of diabetic foveal edema: contact lens biomicroscopy compared with optical coherence tomography. Arch Ophthalmol. 2004;122(3):330\u20135.","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"203_CR15","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s00347-004-0996-2","volume":"101","author":"E Reinthal","year":"2004","unstructured":"Reinthal E, V\u00f6lker M, Freudenthaler N, Gr\u00fcb M, Zierhut M, Schlote T. Optical coherence tomography in the diagnosis and follow-up of patients with uveitic macular edema. Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft. 2004;101(12):1181\u20138.","journal-title":"Der Ophthalmologe: Zeitschrift der Deutschen Ophthalmologischen Gesellschaft"},{"key":"203_CR16","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.2147\/OPTH.S40268","volume":"7","author":"R Karim","year":"2013","unstructured":"Karim R, Sykakis E, Lightman S, Fraser-Bell S. Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis. Clin Ophthalmol. 2013;7:1109\u201344.","journal-title":"Clin Ophthalmol"},{"issue":"9","key":"203_CR17","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1016\/j.ophtha.2013.01.069","volume":"120","author":"JH Kempen","year":"2013","unstructured":"Kempen JH, Sugar EA, Jaffe GJ, Acharya NR, Dunn JP, Elner SG, et al. Fluorescein angiography versus optical coherence tomography for diagnosis of uveitic macular edema. Ophthalmology. 2013;120(9):1852\u20139.","journal-title":"Ophthalmology"},{"issue":"11","key":"203_CR18","doi-asserted-by":"crossref","first-page":"1916.e1","DOI":"10.1016\/j.ophtha.2005.06.009","volume":"112","author":"H Kok","year":"2005","unstructured":"Kok H, Lau C, Maycock N, McCluskey P, Lightman S. Outcome of intravitreal triamcinolone in uveitis. Ophthalmology. 2005;112(11):1916.e1\u20137.","journal-title":"Ophthalmology"},{"issue":"5","key":"203_CR19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/09273940802209153","volume":"16","author":"P Venkatesh","year":"2008","unstructured":"Venkatesh P, Kumar CS, Abbas Z, Garg S. Comparison of the efficacy and safety of different methods of posterior subtenon injection. Ocul Immunol Inflamm. 2008;16(5):217\u201323.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"203_CR20","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1442-9071.2005.00904.x","volume":"33","author":"V Menezo","year":"2005","unstructured":"Menezo V, Lau C, Comer M, Lightman S. Clinical outcome of chronic immunosuppression in patients with non-infectious uveitis. Clin Exp Ophthalmol. 2005;33(1):16\u201321.","journal-title":"Clin Exp Ophthalmol"},{"issue":"7234","key":"203_CR21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bmj.320.7234.555","volume":"320","author":"PJ McCluskey","year":"2000","unstructured":"McCluskey PJ, Towler HM, Lightman S. Regular review: management of chronic uveitis. BMJ. 2000;320(7234):555\u20138.","journal-title":"BMJ"},{"issue":"7","key":"203_CR22","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1136\/bjo.2008.153874","volume":"93","author":"CM Deuter","year":"2009","unstructured":"Deuter CM, Kotter I, Gunaydin I, Stubiger N, Doycheva DG, Zierhut M. Efficacy and tolerability of interferon alpha treatment in patients with chronic cystoid macular oedema due to non-infectious uveitis. Br J Ophthalmol. 2009;93(7):906\u201313.","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"203_CR23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10792-008-9200-z","volume":"29","author":"P Neri","year":"2009","unstructured":"Neri P, Mariotti C, Cimino L, Mercanti L, Giovannini A. Long-term control of cystoid macular oedema in noninfectious uveitis with Mycophenolate Mofetil. Int Ophthalmol. 2009;29(3):127\u201333.","journal-title":"Int Ophthalmol"},{"issue":"4","key":"203_CR24","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.ophtha.2008.10.033","volume":"116","author":"SR Taylor","year":"2009","unstructured":"Taylor SR, Habot-Wilner Z, Pacheco P, Lightman SL. Intraocular methotrexate in the treatment of uveitis and uveitic cystoid macular edema. Ophthalmology. 2009;116(4):797\u2013801.","journal-title":"Ophthalmology"},{"issue":"4","key":"203_CR25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.ajo.2004.04.066","volume":"138","author":"NN Markomichelakis","year":"2004","unstructured":"Markomichelakis NN, Theodossiadis PG, Pantelia E, Papaefthimiou S, Theodossiadis GP, Sfikakis PP. Infliximab for chronic cystoid macular edema associated with uveitis. Am J Ophthalmol. 2004;138(4):648\u201350.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"203_CR26","doi-asserted-by":"crossref","first-page":"303-9. e2","DOI":"10.1016\/j.ajo.2009.03.028","volume":"148","author":"NR Acharya","year":"2009","unstructured":"Acharya NR, Hong KC, Lee SM. Ranibizumab for refractory uveitis-related macular edema. Am J Ophthalmol. 2009;148(2):303-9. e2.","journal-title":"Am J Ophthalmol"},{"key":"203_CR27","unstructured":"NIHR, Research NIfH. James Lind Alliance | Ocular inflammatory disease top 10 2015 [15\/10\/2015].Available from: http:\/\/www.jla.nihr.ac.uk\/top-tens\/sight-loss-and-vision-psp-top-10s\/ocular-inflammatory-disease-top-10 ."},{"issue":"5","key":"203_CR28","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336\u201341.","journal-title":"Int J Surg"},{"key":"203_CR29","doi-asserted-by":"crossref","DOI":"10.1002\/9780470712184","volume-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series","author":"JP Higgins","year":"2008","unstructured":"Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions: Cochrane book series. Chichester, England, Hoboken, NJ: Wiley Blackwell; 2008."},{"key":"203_CR30","unstructured":"Wells G, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2000 [20\/10\/2015].Available from: http:\/\/www.ohri.ca\/programs\/clinical_epdemiology\/Oxford.asp ."},{"issue":"11","key":"203_CR31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539\u201358.","journal-title":"Stat Med"},{"issue":"10","key":"203_CR32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.jclinepi.2007.11.010","volume":"61","author":"JL Peters","year":"2008","unstructured":"Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol. 2008;61(10):991\u20136.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"203_CR33","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.jval.2011.04.002","volume":"14","author":"JP Jansen","year":"2011","unstructured":"Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, et al. Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1. Value Health. 2011;14(4):417\u201328.","journal-title":"Value Health"},{"issue":"7700","key":"203_CR34","first-page":"932","volume":"338","author":"F Song","year":"2009","unstructured":"Song F, Loke YK, Walsh T, Glenny A-M, Eastwood AJ, Altman DG. Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: survey of published systematic reviews. BMJ. 2009;338(7700):932\u20135.","journal-title":"BMJ"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0203-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-016-0203-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T21:23:36Z","timestamp":1692221016000},"score":1,"resource":{"primary":{"URL":"http:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-016-0203-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,13]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1186\/s13643-016-0203-y","relation":{},"ISSN":["2046-4053"],"issn-type":[{"type":"electronic","value":"2046-4053"}],"subject":[],"published":{"date-parts":[[2016,2,13]]},"article-number":"29"}}